Search Results - "YOSHIFUJI, Hajime"

Refine Results
  1. 1

    Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy by Yoshifuji, Hajime

    Published in Modern rheumatology (04-03-2019)
    “…Takayasu arteritis (TAK) and giant cell arteritis (GCA) affect mainly large- and medium-sized arteries. In refractory cases, vascular remodeling progresses and…”
    Get full text
    Journal Article
  2. 2

    Glucocorticoids in the treatment of IgG4-related disease—Prospects for new international treatment guidelines by Yoshifuji, Hajime, Umehara, Hisanori

    Published in Modern rheumatology (02-03-2023)
    “…ABSTRACT Immunoglobulin G4-related disease (IgG4-RD) is a chronic fibro-inflammatory disease that may cause dysfunction in various organs. Worldwide…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Roles of cytotoxic lymphocytes and MIC/LILR families in pathophysiology of Takayasu arteritis by Yoshifuji, Hajime, Terao, Chikashi

    Published in Inflammation and Regeneration (02-06-2020)
    “…Takayasu arteritis (TAK) affects the aorta and its primary branches, mainly in young women. In its advanced stages, it can cause severe complications, such as…”
    Get full text
    Journal Article
  7. 7

    TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease by Shirakashi, Mirei, Nishida, Yuri, Nakashima, Ran, Fujimoto, Masakazu, Hiwa, Ryosuke, Tsuji, Hideaki, Kitagori, Koji, Akizuki, Shuji, Morinobu, Akio, Yoshifuji, Hajime

    Published in Scientific reports (05-02-2024)
    “…TAFRO syndrome is an acute systemic inflammatory disease characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis/renal dysfunction, and…”
    Get full text
    Journal Article
  8. 8

    Recent advances in Takayasu arteritis by Terao, Chikashi, Yoshifuji, Hajime, Mimori, Tsuneyo

    “…Takayasu arteritis (TAK) is a relatively rare systemic vasculitis mainly affecting the aorta and its large branches. While patients with TAK are more…”
    Get full text
    Journal Article
  9. 9

    The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody by Nakashima, Ran, Imura, Yoshitaka, Kobayashi, Shio, Yukawa, Naoichiro, Yoshifuji, Hajime, Nojima, Takaki, Kawabata, Daisuke, Ohmura, Koichiro, Usui, Takashi, Fujii, Takao, Okawa, Katsuya, Mimori, Tsuneyo

    Published in Rheumatology (Oxford, England) (01-03-2010)
    “…Objectives. Various autoantibodies are detected in the sera of PM/DM patients. Some of them are specific to PM/DM patients and closely associated with clinical…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab by Gon, Yoshie, Yoshifuji, Hajime, Nakajima, Toshiki, Murakami, Kosaku, Nakashima, Ran, Ohmura, Koichiro, Mimori, Tsuneyo, Terao, Chikashi

    Published in Modern rheumatology (04-05-2021)
    “…Biologics have been used to treat refractory Takayasu arteritis (TAK), but their efficacy and safety have not been sufficiently evaluated. We extracted…”
    Get full text
    Journal Article
  12. 12

    Expression of S100A8 protein on B cells is associated with disease activity in patients with systemic lupus erythematosus by Kitagori, Koji, Oku, Takuma, Wakabayashi, Masaki, Nakajima, Tomoya, Nakashima, Ran, Murakami, Kosaku, Hirayama, Yoshitaka, Ishihama, Yasushi, Ohmura, Koichiro, Morinobu, Akio, Mimori, Tsuneyo, Yoshifuji, Hajime

    Published in Arthritis research & therapy (10-05-2023)
    “…Systemic lupus erythematosus (SLE) is an intractable disease characterized by autoantibody production and autoreactive B and T cell proliferation. Although…”
    Get full text
    Journal Article
  13. 13

    Anti-integrin αvβ6 antibody in Takayasu arteritis patients with or without ulcerative colitis by Ishikawa, Yuki, Yoshida, Hiroyuki, Yoshifuji, Hajime, Ohmura, Koichiro, Origuchi, Tomoki, Ishii, Tomonori, Mimori, Tsuneyo, Morinobu, Akio, Shiokawa, Masahiro, Terao, Chikashi

    Published in Frontiers in immunology (09-05-2024)
    “…It has been well documented that Takayasu arteritis (TAK) and ulcerative colitis (UC) coexist in the same patients. characterizes the co-occurrence, which is…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Neutrophils are essential as a source of IL-17 in the effector phase of arthritis by Katayama, Masaki, Ohmura, Koichiro, Yukawa, Naoichiro, Terao, Chikashi, Hashimoto, Motomu, Yoshifuji, Hajime, Kawabata, Daisuke, Fujii, Takao, Iwakura, Yoichiro, Mimori, Tsuneyo

    Published in PloS one (06-05-2013)
    “…Th17 has been shown to have a pivotal role in the development of arthritis. However, the role of IL-17 in the T cell-independent effector phase has not fully…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies by Yoshifuji, Hajime

    “…Various autoantibodies are seen in idiopathic inflammatory myopathies. Among myositis-specific antibodies, anti-aminoacyl-tRNA synthetase and anti-melanoma…”
    Get full text
    Journal Article Book Review
  19. 19

    Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes by Miyagawa-Hayashino, Aya, Yoshifuji, Hajime, Kitagori, Koji, Ito, Shinji, Oku, Takuma, Hirayama, Yoshitaka, Salah, Adeeb, Nakajima, Toshiki, Kiso, Kaori, Yamada, Norishige, Haga, Hironori, Tsuruyama, Tatsuaki

    Published in Arthritis research & therapy (30-01-2018)
    “…Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease in which dysregulation of B cells has been recognized. Here, we searched for potential…”
    Get full text
    Journal Article
  20. 20

    Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease by Handa, Tomohiro, Matsui, Shoko, Yoshifuji, Hajime, Kodama, Yuzo, Yamamoto, Hiroshi, Minamoto, Seijiro, Waseda, Yuko, Sato, Yasuharu, Kubo, Keishi, Mimori, Tsuneyo, Chiba, Tsutomu, Hirai, Toyohiro, Mishima, Michiaki

    Published in Modern rheumatology (03-09-2018)
    “…Objectives: Serum soluble interleukin-2 (IL-2) receptor (sIL-2R) might reflect disease activity in immunoglobulin G4-related disease (IgG4-RD). We aimed to…”
    Get full text
    Journal Article